Locally produced peginterferon as an opportunity to treat HCV in low and mid-income countries.
Blum
H E
HE
D000998:Antiviral Agents / Q000600:supply & distribution* / Q000627:therapeutic use; D004337:Drug Carriers; D004345:Drug Industry; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000600:supply & distribution* / Q000627:therapeutic use; D007492:Iran; D011092:Polyethylene Glycols / Q000600:supply & distribution* / Q000627:therapeutic use; D011994:Recombinant Proteins
D000998:Antiviral Agents; D004337:Drug Carriers; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a